Literature DB >> 15100720

Experimental therapeutics in transgenic mouse models of Huntington's disease.

M Flint Beal1, Robert J Ferrante.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15100720     DOI： 10.1038/nrn1386

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN： 1471-003X            Impact factor:   34.870


× No keyword cloud information.
  61 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

Review 2.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 3.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 4.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

Review 5.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

6.  Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.

Authors:  Arpit Mehrotra; Abhilasha Sood; Rajat Sandhir
Journal:  Mol Cell Biochem       Date:  2015-09-15       Impact factor: 3.396

7.  Long-term test-retest reliability of functional MRI in a classification learning task.

Authors:  Adam R Aron; Mark A Gluck; Russell A Poldrack
Journal:  Neuroimage       Date:  2005-09-01       Impact factor: 6.556

Review 8.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.

Authors:  William J Wolfgang; Todd W Miller; Jack M Webster; James S Huston; Leslie M Thompson; J Lawrence Marsh; Anne Messer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

Review 10.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.